NANOG and cancer: It is upregulated during liver regeneration and suppresses stemness-associated transcription factors such as SOX2 and NANOG. In cancer models, MBNL2 acts as a tumor suppressor, limiting proliferation and invasiveness, while its expression declines in more aggressive tumors.